Zenas BioPharma Inc. (ZBIO)
Zenas BioPharma Max Pain By Strike
ZBIO trades at $15.86, 26.9% above the near-term max pain of $12.5 expiring Sep 19, 2025 (30 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$17.5), signaling increased put positioning or downside protection. High dispersion in max pain levels suggests competing forces and potential volatility.
Zenas BioPharma Max Pain By Expiry
Max pain for ZBIO shows a downward trend from 17.5 to 2.5, indicating bearish sentiment or hedging activity. The 150% spread signals divergent expectations across timeframes. Most levels below 15.86 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 12.5 | -3.36 (-21.19%) |
| Oct 17, 2025 | 2.5 | -13.36 (-84.24%) |
| Nov 21, 2025 | 7.5 | -8.36 (-52.71%) |
| Feb 20, 2026 | 17.5 | 1.64 (10.34%) |